There was no statistically significant difference in serum survivin level between children with JIA newly diagnosed comparing to children with JIA biologically treated (Me 22.61 pg/ml (IQR 17.37–35.31) vs Me 24.72 pg/ml (IQR 19.46–40.64); p = 0.68). The gene discussed is BIRC5; the disease is juvenile idiopathic arthritis.